Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 286–300 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-196
Fungal Genome Sequencing (Illumina Reference‑Based Analysis) Test

This test identifies fungal species, resistance genes, and virulence factors present in a clinical sample using next-generation sequencing.

Whole blood (EDTA); sterile tissue, BAL fluid, or CSF 4 weeks 2,500.00 AED
View
View test specifications and preparation
What it measures
["Fungal DNA presence", "Fungal species identification", "Antifungal resistance genes", "Virulence factors"]
Parameters
[]
Preparation
["Suspend antifungal medications for at least 2 weeks prior, unless medically contraindicated.", "No prolonged fasting required.", "Inform the team of any recent antibiotic use."]
Indications
["Complex or recurrent fungal infections", "Immunocompromised patients", "Unexplained inflammation", "Negative or inconclusive culture results"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103207-0 ICD-10: B37.9, B44.9, B49
Clinical summary
This test identifies fungal species, resistance genes, and virulence factors present in a clinical sample using next-generation sequencing.
TEST-302
Fungal Genome Sequencing and Reference-Based Analysis Test

This test identifies fungal species and detects antifungal resistance genes using next-generation sequencing.

Whole Blood (Peripheral) or Tissue Biopsy 8 weeks 5,500.00 AED
View
View test specifications and preparation
What it measures
["Fungal species identification", "Antifungal resistance gene detection"]
Parameters
[]
Preparation
["No fasting required", "Do not discontinue prescribed antifungal medications or immunosuppressive therapy without consulting your treating physician"]
Indications
["Suspected invasive fungal infection", "Immunocompromised patients", "Failure of conventional diagnostics", "Need for targeted antifungal therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 74975-6 ICD-10: B49
Clinical summary
This test identifies fungal species and detects antifungal resistance genes using next-generation sequencing.
TEST-296
Fungal Genome Sequencing, De Novo Assembly and Annotation (Illumina) Test

This test identifies fungal pathogens and their antimicrobial resistance profiles using whole genome sequencing.

Peripheral whole blood, serum, or plasma 8 Weeks 5,000.00 AED
View
View test specifications and preparation
What it measures
["Fungal genomic DNA", "Antimicrobial resistance genes", "Virulence factors"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent antifungal prophylaxis"]
Indications
["Identification of emerging fungal pathogens", "Dissection of antifungal resistance mechanisms", "Guiding precision medicine in immunocompromised patients", "Culture-negative suspected fungal infections"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82345-6 ICD-10: B49
Clinical summary
This test identifies fungal pathogens and their antimicrobial resistance profiles using whole genome sequencing.
TEST-3241
G6PD Deficiency Genetic Test

This test identifies pathogenic variants in the G6PD gene using next-generation sequencing to diagnose G6PD deficiency.

Whole Blood, Extracted DNA, or FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["G6PD gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions (within 3 months)"]
Indications
["Suspected G6PD deficiency", "Family history of G6PD deficiency", "Recurrent hemolytic episodes", "Pre-marital screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 32578-2 ICD-10: D55.0
Clinical summary
This test identifies pathogenic variants in the G6PD gene using next-generation sequencing to diagnose G6PD deficiency.
TEST-26
Ganciclovir Resistance Detection Test

This test detects specific mutations in the CMV UL97 and UL54 genes associated with resistance to ganciclovir antiviral therapy.

EDTA whole blood 10–12 business days 1,000.00 AED
View
View test specifications and preparation
What it measures
["CMV UL97 gene mutations", "CMV UL54 gene mutations"]
Parameters
[]
Preparation
["No fasting required", "No special preparation needed"]
Indications
["Suspected ganciclovir resistance in CMV infection", "Clinical or virological failure on ganciclovir therapy", "Patients with immunosuppression (e.g., transplant recipients, HIV/AIDS patients)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101184-0 ICD-10: B25.9
Clinical summary
This test detects specific mutations in the CMV UL97 and UL54 genes associated with resistance to ganciclovir antiviral therapy.
TEST-895
GAPDH Gene Load Test

This test quantifies viral nucleic acid relative to the GAPDH housekeeping gene.

Whole blood (EDTA tube) or cultured cells 24 hours (phone) / 36 hours (email) after sample receipt 600.00 AED
View
View test specifications and preparation
What it measures
["Viral nucleic acid", "GAPDH gene expression"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}]
Preparation
["No fasting required", "Bring detailed clinical history including current medications and previous viral load results", "Sign informed consent document"]
Indications
["Monitoring viral infections", "Assessing treatment efficacy", "Adjusting antiviral therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 20416-4 ICD-10: B34.9
Clinical summary
This test quantifies viral nucleic acid relative to the GAPDH housekeeping gene.
TEST-1557
Gastro-Intestinal Cancer Gene Panel Test

This test evaluates multiple genes associated with an increased risk of hereditary gastrointestinal cancers.

Peripheral Whole Blood 4–6 Weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Inherited mutations in genes linked to GI cancers"]
Parameters
[]
Preparation
["Wait at least 2 weeks after acute infection or blood transfusion"]
Indications
["Individuals with a personal or family history of gastrointestinal cancers", "Individuals with multiple primary cancers", "Individuals with early-onset cancer", "Individuals seeking to understand inherited cancer syndrome risks"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93035-9 ICD-10: Z15.09
Clinical summary
This test evaluates multiple genes associated with an increased risk of hereditary gastrointestinal cancers.
TEST-527
Gastrointestinal Stromal Tumor (GIST) Cancer Targeted Gene Panel Test

This test evaluates the presence of specific mutations in genes like KIT, PDGFRA, BRAF, and SDH within a GIST tumor sample.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block – Archival Specimen 10 Working Days 3,500.00 AED
View
View test specifications and preparation
What it measures
["KIT gene mutations (exons 9, 11, 13, 17)", "PDGFRA gene mutations (exons 12, 14, 18)", "BRAF gene mutations", "SDH gene modifications"]
Parameters
[]
Preparation
["Provide a formalin-fixed paraffin-embedded (FFPE) tissue block.", "Ensure minimum 20% tumor cellularity.", "Provide a fully completed NGS Test Requisition Form (Form 40).", "Provide signed informed consent for genetic testing."]
Indications
["Diagnosis of GIST", "Guiding targeted therapy selection for GIST", "Prognosis assessment in GIST"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100350-6 ICD-10: C26.1
Clinical summary
This test evaluates the presence of specific mutations in genes like KIT, PDGFRA, BRAF, and SDH within a GIST tumor sample.
TEST-3073
GATA4 Gene Atrial Septal Defect Type 2 Genetic Test

This test identifies pathogenic variants in the GATA4 gene associated with autosomal dominant atrial septal defect type 2.

Peripheral whole blood (EDTA tube) or dried blood spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GATA4 gene sequence", "Copy Number Variations (CNVs) in GATA4"]
Parameters
[]
Preparation
["No specific fasting required.", "Do not discontinue cardiac medications without consulting a physician."]
Indications
["Diagnosis of ASD Type 2", "Family cascade screening for ASD Type 2", "Risk stratification for individuals with family history"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82533-6 ICD-10: Q21.1, Z15.09, Z13.6
Clinical summary
This test identifies pathogenic variants in the GATA4 gene associated with autosomal dominant atrial septal defect type 2.
TEST-6323
GBA Gene Analysis for Gaucher Disease Type 2 (NGS) Test

This test evaluates the GBA gene for pathogenic variants associated with Gaucher disease type 2.

Whole Blood, Extracted DNA, or FTA Card Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GBA gene sequence", "Pathogenic variants (SNVs, indels, splice-site mutations)"]
Parameters
[]
Preparation
["Pre- and post-test genetic counseling is mandatory.", "Signed informed consent and a three-generation pedigree chart are required.", "Parental consent and court-approved counseling documentation are required for minors."]
Indications
["Suspected Gaucher disease type 2", "Neonatal screening", "Family history of Gaucher disease", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: E75.22
Clinical summary
This test evaluates the GBA gene for pathogenic variants associated with Gaucher disease type 2.
TEST-6393
GBA Gene Gaucher Disease Type 1 Genetic Test (NGS)

This genetic test identifies pathogenic mutations in the GBA gene associated with Gaucher disease type 1.

Peripheral Blood (or Buccal Swab) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GBA gene"]
Parameters
[]
Preparation
["No special preparation required", "Continue all prescribed medications", "Pre-genetic counselling session advised", "Inform nurse of bleeding disorders or anticoagulant use"]
Indications
["Suspected Gaucher disease type 1", "Family history of Gaucher disease", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21668-1 ICD-10: E75.22
Clinical summary
This genetic test identifies pathogenic mutations in the GBA gene associated with Gaucher disease type 1.
TEST-6331
GBA Gene Gaucher Disease, Perinatal Lethal Genetic Test

This test identifies pathogenic variants in the GBA gene associated with the severe, perinatal lethal form of Gaucher disease.

Whole Blood (EDTA), Dried Blood Spot (FTA card), or Extracted DNA 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GBA gene"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of perinatal lethal Gaucher disease", "Family history of Gaucher disease", "Reproductive planning for carriers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21697-8 ICD-10: E75.22
Clinical summary
This test identifies pathogenic variants in the GBA gene associated with the severe, perinatal lethal form of Gaucher disease.
TEST-4215
GCH1 Gene DYT5A Genetic Test

This test evaluates the GCH1 gene for pathogenic variants associated with dopa-responsive dystonia (DYT5A). It identifies single nucleotide variants and copy-number variations caus...

Whole Blood (EDTA), Extracted DNA, FTA Card (single drop) 12–14 business days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GCH1 gene", "Single nucleotide variants (SNVs)", "Copy-number variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected dopa-responsive dystonia (DYT5A)", "Differential diagnosis of dystonia syndromes", "Family history of DYT5A"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95623-1 ICD-10: G24.1, G24.8, Z13.858
Clinical summary
This test evaluates the GCH1 gene for pathogenic variants associated with dopa-responsive dystonia (DYT5A). It identifies single nucleotide variants and copy-number variations causative of the condition.
TEST-6079
GCK Gene MODY Type 2 Genetic Test

This test evaluates the glucokinase (GCK) gene for variants associated with Maturity-Onset Diabetes of the Young type 2 (MODY2).

Peripheral whole blood (EDTA), extracted DNA, or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Glucokinase (GCK) gene variants", "Genetic predisposition to MODY2"]
Parameters
[]
Preparation
["No fasting required", "Mandatory genetic counselling session prior to testing"]
Indications
["Diagnosis of MODY2", "Differentiation of mild hyperglycaemia from aggressive diabetes", "Guiding personalised diabetes treatment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92815-3 ICD-10: E11.8
Clinical summary
This test evaluates the glucokinase (GCK) gene for variants associated with Maturity-Onset Diabetes of the Young type 2 (MODY2).
TEST-1309
Genetic Mapping for Gynecological Disorders Test

This test evaluates the genome for copy number variations and loss of heterozygosity linked to gynecological disorders.

Whole Blood (EDTA) 8 weeks 2,300.00 AED
View
View test specifications and preparation
What it measures
["Copy Number Variants (CNVs)", "Loss of Heterozygosity (LOH)", "Single Nucleotide Polymorphisms (SNPs)"]
Parameters
[]
Preparation
["Complete the mandatory Genome Mapping Consent Form (Form 26).", "Avoid blood transfusions within two weeks prior to the test.", "No fasting is required."]
Indications
["Unexplained infertility", "Recurrent pregnancy loss", "Congenital reproductive anomalies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81258-9 ICD-10: N97.9
Clinical summary
This test evaluates the genome for copy number variations and loss of heterozygosity linked to gynecological disorders.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area